Stem cells to optimize match between patient and medication

One of the biggest barriers to the development of new medical therapies is the cost of taking a new drug from a concept in a lab to a proven treatment. Estimates of these costs range from $100-million to $1.2-billion for each new drug that makes it to market, and a substantial chunk of this funding is consumed by establishing that a drug is both safe and effective. A new initiative combining breakthroughs in research, private sector support, and a non-profit committed to regenerative medicine is dedicated to improving this process.

View the original article here: Stem cells to optimize match between patient and medication – National Post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend